Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNichols plc Regulatory News (NICL)

Share Price Information for Nichols plc (NICL)

Share Price is delayed by 15 minutes
Get Live Data
942.00    4.00 (0.43%)
Bid:
934.00
Ask:
952.00
Spread: 18.00 (1.927%)
Market Cap: £344.43m
NICL Live PriceLast checked at - London Stock Exchange

Intraday Nichols plc Share Chart

Board Appointment

30 Nov 2010 07:00

RNS Number : 0093X
Nichols PLC
30 November 2010
 



Date:

Embargoed until 07.00am, 30 November 2010

 

Contacts:

John Nichols, Non-Executive Chairman

Brendan Hynes, Group Chief Executive

Tim Croston, Group Finance Director

Nichols plc

Telephone: 01925 222222

Website:www.nicholsplc.co.uk

Alistair Mackinnon-Musson

Nathan Field

Mark Brady

Matthew Cheetham

Hudson Sandler

Brewin Dolphin Ltd

Telephone:020 7796 4133

(Nominated Adviser)

Email: nichols@hspr.com

Telephone: 0845 213 4729

Website: www.brewincorporate.co.uk

 

Photographs available:

On request from Hudson Sandler, as above

 

 

Nichols plc

BOARD APPOINTMENT

 

Nichols plc, the soft drinks group, announces that Mr John Longworth (aged 52)has been appointed to the Board as a Non-Executive Director.

 

John is currently a Non-Executive Director of the Cooperative Group and is also a Competition Commission panel member. He has a strong background and extensive experience in FMCG and the retail sector, as well as building strong brands on an international scale. Previous roles have included being a Main Board Director of Asda and a Director of Tesco Stores.

 

John will be replacing current Non-Executive Director Jonathan Diggines. Jonathan, who is Chief Executive of Enterprise Ventures has served since 1995, and is stepping down to enable the Board to be refreshed in line with 'Best Practice'.

 

Nichols plc wishes to place on record its sincere thanks to Jonathan, who has been an excellent member of the Board and whose wise and valuable counsel has been much appreciated over the years.

 

Commenting John Nichols, Non Executive Chairman, said:

 

"We are absolutely delighted to have attracted someone of John's calibre to our Board. He brings with him a vast wealth of relevant experience that will help take us onto our next level of development and growth".

 

"I would also like to express our profound gratitude to Jonathan for all the help and guidance he has provided to me personally and to the Board over many years. He has made an enormous contribution and helped shape us into the strong and profitable Group we are today".

 

 

Notes:

Current directorships for John Longworth:

Co-Operative Group Non-Executive Director

Barts Hospitals Trust Executive Director

SVA Ltd (professional services business) Chairman

 

Previous directorships for John Longworth:

Tesco plc

York Hospitals Foundation Trust - Non Executive Director

 

There are no further matters in connection with the appointment of John Longworth that need to be disclosed under Schedule Two paragraph (g) of the AIM Rules.

 

 

- ENDS -

 

 

Notes to Editors:

 

Nichols plc is a highly focused soft drinks and dispensed cold drinks business, comprising two operations:

 

1. Soft Drinks (sales and marketing of the Vimto brand throughout the world, where it is now available in over 65 countries and of the Panda & Sunkist brands in the UK) and

 

2. Dispense Operation (namely the Cabana, Beacon, Cariel, Ben Shaws (dispense) & Dayla soft drinks on draught 'dispense' businesses)

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGGCAGUPUGMB
Date   Source Headline
6th Apr 20215:48 pmRNSHolding(s) in Company
22nd Mar 20211:00 pmRNSPublication of Annual Report and Notice of AGM
8th Mar 20214:41 pmRNSSecond Price Monitoring Extn
8th Mar 20214:35 pmRNSPrice Monitoring Extension
8th Mar 202112:57 pmRNSDirector/PDMR Shareholding
5th Mar 20214:45 pmRNSDirector/PDMR Shareholding
4th Mar 20214:17 pmRNSDirector/PDMR Shareholding
3rd Mar 20217:00 amRNS2020 Preliminary Result
1st Feb 20214:40 pmRNSSecond Price Monitoring Extn
1st Feb 20214:35 pmRNSPrice Monitoring Extension
12th Jan 20217:00 amRNSTrading Update
21st Dec 20204:40 pmRNSSecond Price Monitoring Extn
21st Dec 20204:35 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSDirector Share Awards
3rd Dec 20204:36 pmRNSPrice Monitoring Extension
1st Dec 20209:45 amRNSPDMR Dealing & Director’s Interest
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:38 pmRNSPrice Monitoring Extension
19th Nov 20207:00 amRNSTrading Update
16th Nov 20204:41 pmRNSSecond Price Monitoring Extn
16th Nov 20204:36 pmRNSPrice Monitoring Extension
11th Nov 20204:40 pmRNSSecond Price Monitoring Extn
11th Nov 20204:35 pmRNSPrice Monitoring Extension
30th Sep 20201:22 pmRNSDirector/PDMR Shareholding
22nd Jul 20207:01 amRNSDirectorate Change and Relationship Agreement
22nd Jul 20207:00 amRNS2020 Interim Results & Board Changes
3rd Jul 202012:07 pmRNSSecond Price Monitoring Extn
3rd Jul 202012:02 pmRNSPrice Monitoring Extension
24th Jun 202012:07 pmRNSSecond Price Monitoring Extn
24th Jun 202012:02 pmRNSPrice Monitoring Extension
11th Jun 20207:00 amRNSGrant of SAYE Options and PDMR Dealings
8th Jun 20204:40 pmRNSSecond Price Monitoring Extn
8th Jun 20204:36 pmRNSPrice Monitoring Extension
8th Jun 202012:02 pmRNSPrice Monitoring Extension
6th May 202010:07 amRNSDirector/PDMR Shareholding
29th Apr 20204:35 pmRNSPrice Monitoring Extension
29th Apr 202011:33 amRNSResult of AGM
29th Apr 202011:11 amRNSPDMR/PCA Dealing
17th Apr 20204:42 pmRNSSecond Price Monitoring Extn
17th Apr 20204:36 pmRNSPrice Monitoring Extension
15th Apr 202012:02 pmRNSPrice Monitoring Extension
8th Apr 20207:00 amRNSAGM
31st Mar 20207:00 amRNSCOVID-19 Trading Update
18th Mar 20204:41 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension
26th Feb 20207:00 amRNSPreliminary Results
10th Jan 20204:34 pmRNSHolding(s) in Company
9th Jan 20207:00 amRNS2019 Trading Update
23rd Dec 20197:00 amRNSTrading update
9th Dec 20193:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.